The role of immune-reactions in patients with COVID-19

Recruiting

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00021810
• Lead Sponsor: niversitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

confirmed COVID-19 infection or suspicion of COVID-19

Exclusion Criteria

For the prospective investigation: lack of consent, correctional facilities.
In general (both prospective and retrospective): patients < 18 years.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analysis of immune reactions in combination with clinical parameters.<br>Blood-, stool-, and urine samples are taken at the day of admission and at day 7, 10, 13 (counted after symptom onset) and eyery further third day, and in addition on days of deterioration.

Secondary Outcome Measures

Name	Time	Method
Collection and anaylsis of follow-up data of patients on a regular follow-up intervall basis with special focus on pulmonary long-term outcome.